+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Marine Derived Drugs Market by Type (Ether, Peptide, Phenol), Source (Algae, Invertebrates, Microorganisms), Mode of Delivery - Forecast 2024-2030- Product Image
Global Marine Derived Drugs Market by Type (Ether, Peptide, Phenol), Source (Algae, Invertebrates, Microorganisms), Mode of Delivery - Forecast 2024-2030- Product Image
Sale

Global Marine Derived Drugs Market by Type (Ether, Peptide, Phenol), Source (Algae, Invertebrates, Microorganisms), Mode of Delivery - Forecast 2024-2030

  • PDF Icon

    Report

  • 196 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4904827
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Marine Derived Drugs Market size was estimated at USD 12.47 billion in 2023, USD 13.58 billion in 2024, and is expected to grow at a CAGR of 9.00% to reach USD 22.81 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Marine Derived Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Marine Derived Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Marine Derived Drugs Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aker BioMarine ASA, Amicogen, Inc., Amway Corporation, Aphios Corporation, BASF SE, BioMarin, Croda International PLC, Koninklijke DSM N.V., Nordic Naturals, and Pharma Marine AS.

Market Segmentation & Coverage

This research report categorizes the Marine Derived Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Ether
    • Peptide
    • Phenol
    • Steroid
  • Source
    • Algae
    • Invertebrates
    • Microorganisms
  • Mode of Delivery
    • Anti-Cardiovascular
    • Anti-Inflammatory
    • Anti-Microbial
    • Anti-Tumor
    • Anti-Viral
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Marine Derived Drugs Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Marine Derived Drugs Market?
  3. What are the technology trends and regulatory frameworks in the Marine Derived Drugs Market?
  4. What is the market share of the leading vendors in the Marine Derived Drugs Market?
  5. Which modes and strategic moves are suitable for entering the Marine Derived Drugs Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Marine Derived Drugs Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. High prevalence of unmet medical needs
5.1.1.2. Increasing initiatives for preserving marine biodiversity
5.1.1.3. Rising incidence of chronic ailments
5.1.2. Restraints
5.1.2.1. Complexity in drug development from marine sources due to environmental conditions and microorganisms residing in the marine animal
5.1.3. Opportunities
5.1.3.1. Innovation of pharmaceutical products
5.1.3.2. Advances in cancer therapy and immune signaling
5.1.3.3. Increase in pharmacokinetic research on marine-derived compounds
5.1.4. Challenges
5.1.4.1. Lack of awareness and social taboos commonly associated with advanced medications
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Marine Derived Drugs Market, by Type
6.1. Introduction
6.2. Ether
6.3. Peptide
6.4. Phenol
6.5. Steroid
7. Marine Derived Drugs Market, by Source
7.1. Introduction
7.2. Algae
7.3. Invertebrates
7.4. Microorganisms
8. Marine Derived Drugs Market, by Mode of Delivery
8.1. Introduction
8.2. Anti-Cardiovascular
8.3. Anti-Inflammatory
8.4. Anti-Microbial
8.5. Anti-Tumor
8.6. Anti-Viral
9. Americas Marine Derived Drugs Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Marine Derived Drugs Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Marine Derived Drugs Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Abbott Laboratories
13.1.2. Aker BioMarine ASA
13.1.3. Amicogen, Inc.
13.1.4. Amway Corporation
13.1.5. Aphios Corporation
13.1.6. BASF SE
13.1.7. BioMarin
13.1.8. Croda International PLC
13.1.9. Koninklijke DSM N.V.
13.1.10. Nordic Naturals
13.1.11. Pharma Marine AS
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. MARINE DERIVED DRUGS MARKET RESEARCH PROCESS
FIGURE 2. MARINE DERIVED DRUGS MARKET SIZE, 2022 VS 2030
FIGURE 3. MARINE DERIVED DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. MARINE DERIVED DRUGS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. MARINE DERIVED DRUGS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. MARINE DERIVED DRUGS MARKET DYNAMICS
FIGURE 7. MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 8. MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2022 VS 2030 (%)
FIGURE 10. MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2022 VS 2030 (%)
FIGURE 12. MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 14. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 16. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. MARINE DERIVED DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 22. MARINE DERIVED DRUGS MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. MARINE DERIVED DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. MARINE DERIVED DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. MARINE DERIVED DRUGS MARKET SIZE, BY ETHER, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. MARINE DERIVED DRUGS MARKET SIZE, BY PEPTIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. MARINE DERIVED DRUGS MARKET SIZE, BY PHENOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. MARINE DERIVED DRUGS MARKET SIZE, BY STEROID, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 11. MARINE DERIVED DRUGS MARKET SIZE, BY ALGAE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. MARINE DERIVED DRUGS MARKET SIZE, BY INVERTEBRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. MARINE DERIVED DRUGS MARKET SIZE, BY MICROORGANISMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 15. MARINE DERIVED DRUGS MARKET SIZE, BY ANTI-CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. MARINE DERIVED DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. MARINE DERIVED DRUGS MARKET SIZE, BY ANTI-MICROBIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. MARINE DERIVED DRUGS MARKET SIZE, BY ANTI-TUMOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. MARINE DERIVED DRUGS MARKET SIZE, BY ANTI-VIRAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 30. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 32. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 33. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 35. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 47. CHINA MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. CHINA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 49. CHINA MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 50. INDIA MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. INDIA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 52. INDIA MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 56. JAPAN MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. JAPAN MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 58. JAPAN MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 74. THAILAND MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. THAILAND MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 76. THAILAND MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 84. DENMARK MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. DENMARK MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 86. DENMARK MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 87. EGYPT MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. EGYPT MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 89. EGYPT MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 90. FINLAND MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. FINLAND MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 92. FINLAND MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 93. FRANCE MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. FRANCE MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 95. FRANCE MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 96. GERMANY MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. GERMANY MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 98. GERMANY MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 102. ITALY MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. ITALY MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 104. ITALY MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 111. NORWAY MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. NORWAY MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 113. NORWAY MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 114. POLAND MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. POLAND MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 116. POLAND MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 117. QATAR MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. QATAR MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 119. QATAR MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 129. SPAIN MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. SPAIN MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 131. SPAIN MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 138. TURKEY MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. TURKEY MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 140. TURKEY MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 147. MARINE DERIVED DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 148. MARINE DERIVED DRUGS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 149. MARINE DERIVED DRUGS MARKET LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • Aker BioMarine ASA
  • Amicogen, Inc.
  • Amway Corporation
  • Aphios Corporation
  • BASF SE
  • BioMarin
  • Croda International PLC
  • Koninklijke DSM N.V.
  • Nordic Naturals
  • Pharma Marine AS

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages196
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 13.58 Billion
Forecasted Market Value ( USD ) by 2030 $ 22.81 Billion
Compound Annual Growth Rate9.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Global Marine Derived Drugs Market (2023-2028) Competitive Analysis, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis. - Product Image

Global Marine Derived Drugs Market (2023-2028) Competitive Analysis, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis.

  • Report
  • 184 Pages
  • Global
From
Marine Derived Drugs Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F - Product Image

Marine Derived Drugs Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F

  • Report
  • 188 Pages
  • Global
From
Global Peptide Therapeutics Market by Technology (Hybrid Phase, Liquid Phase, Solid Phase), API Type (CMO, In-house), Drug Class, Application, End User - Forecast 2023-2030 - Product Image

Global Peptide Therapeutics Market by Technology (Hybrid Phase, Liquid Phase, Solid Phase), API Type (CMO, In-house), Drug Class, Application, End User - Forecast 2023-2030

  • Report
  • 186 Pages
  • Global
From
Peptide Therapeutics - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Peptide Therapeutics - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Global Microbial API Market Size, Share & Trends Analysis Report by Hose (Mammalian, Bacterial, Fungal), Type (Antibody, Peptide, Protein), Site, Molecule, End-use, Region, and Segment Forecasts, 2023-2030 - Product Image

Global Microbial API Market Size, Share & Trends Analysis Report by Hose (Mammalian, Bacterial, Fungal), Type (Antibody, Peptide, Protein), Site, Molecule, End-use, Region, and Segment Forecasts, 2023-2030

  • Report
  • 180 Pages
  • Global
From

About the Marine Derived Drug Market

The Marine Derived Drug market is a subset of the biopharmaceutical industry, which focuses on the development and commercialization of drugs derived from marine organisms. These drugs are typically derived from marine organisms such as bacteria, fungi, algae, and invertebrates, and are used to treat a variety of diseases and conditions. Marine derived drugs are often used to treat cancer, infectious diseases, and neurological disorders. The Marine Derived Drug market is highly competitive, with many companies vying for a share of the market. Companies in the market include Amgen, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.